The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NET-02: A multi-center, randomised, phase II trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients (pts) with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma (PD-EP-NEC).
 
Mairead Geraldine McNamara
Consulting or Advisory Role - Ipsen; Shire; Sirtex Medical
Speakers' Bureau - Nucana
Research Funding - Ipsen; Nucana; SERVIER
Travel, Accommodations, Expenses - Bayer
 
Jayne Swain
No Relationships to Disclose
 
Zoe Craig
No Relationships to Disclose
 
Jonathan Wadsley
Honoraria - Eisai; Genzyme
Speakers' Bureau - Eisai; Genzyme
Research Funding - AstraZeneca; Genzyme
Travel, Accommodations, Expenses - Celgene; Genzyme; Imaging Equipment Limited; Ipsen
 
Nicholas Reed
No Relationships to Disclose
 
Olusola Olusesan Faluyi
No Relationships to Disclose
 
Angela Lamarca
Honoraria - Eisai; Nutricia; Nutricia (I)
Speakers' Bureau - Ipsen; Ipsen (I); Merck; Novartis (I); Pfizer; Pfizer (I)
Research Funding - Ipsen; Ipsen (I)
Travel, Accommodations, Expenses - Abbott Nutrition; Advanced Accelerator Applications; Bayer; Celgene; Delcath Systems; Ipsen; Ipsen (I); Mylan; NanoString Technologies (I); Novartis; Pfizer; Sirtex Medical
 
Richard Hubner
Honoraria - Abbott Nutrition; Ipsen
Consulting or Advisory Role - BTG; Shire
Travel, Accommodations, Expenses - Bayer; Celgene
 
Wasat Mansoor
No Relationships to Disclose
 
Debashis Sarker
Honoraria - Bayer; Ipsen; Pfizer; Pfizer (I)
Consulting or Advisory Role - Eisai; Eisai (I); Ipsen (I); Novartis
Travel, Accommodations, Expenses - Bayer; ipsen; MiNA Therapeutics
 
Helen C Howard
No Relationships to Disclose
 
David A. Cairns
Research Funding - Amgen (Inst); Celgene (Inst); Merck Sharp & Dohme (Inst); Takeda (Inst)
 
Tim Meyer
Consulting or Advisory Role - Beigene; Bristol-Myers Squibb; BTG; Eisai; Ipsen; MSD; Tarveda Therapeutics
Research Funding - Bayer (Inst); BTG (Inst); Ipsen (Inst)
 
Juan W. Valle
Honoraria - Ipsen
Consulting or Advisory Role - Agios; AstraZeneca; Delcath Systems; Genoscience Pharma; Incyte; Ipsen; Keocyt; Merck; Mundipharma; Novartis; PCI Biotech; Pfizer; Pieris Pharmaceuticals; QED Therapeutics
Speakers' Bureau - Imaging Equipment Limited; Ipsen; Novartis; Nucana
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Celgene; Nucana